Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 365.9 | 260.1 | 119.1 | 166.6 |
| Revenue growth | 40.7% | 118.4% | -28.5% | |
| Cost of goods sold | 115.5 | 78.3 | 51.9 | 60.1 |
| Gross profit | 250.3 | 181.8 | 67.2 | 106.5 |
| Gross margin | 68.4% | 69.9% | 56.4% | 63.9% |
| Sales and marketing | 160.1 | 111.6 | 50.3 | 61.8 |
| Research and development | 8.4 | 8.2 | 3.4 | 4.6 |
| General and administrative | 106.1 | 98.7 | 30.6 | 26.7 |
| EBITA | -11.9 | -23.3 | -5.3 | 26.0 |
| EBITA margin | -3.3% | -9.0% | -4.5% | 15.6% |
| Amortization of intangibles | 14.9 | 13.3 | 11.8 | 12.5 |
| EBIT | -26.8 | -36.6 | -17.2 | 13.5 |
| EBIT margin | -7.3% | -14.1% | -14.4% | 8.1% |
| Pre-tax income | 45.0 | -377.4 | -38.5 | -2.9 |
| Income taxes | 0.6 | -2.2 | -9.3 | -1.3 |
| Tax rate | 1.4% | 0.6% | 24.2% | 44.2% |
| Net income | 44.4 | -375.1 | -29.2 | -1.6 |
| Net margin | 12.1% | -144.2% | -24.5% | -1.0% |
| |
| Diluted EPS | $0.30 | ($3.67) | ($0.85) | ($0.05) |
| Shares outstanding (diluted) | 148.5 | 102.1 | 34.3 | 32.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|